Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Ferrari

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
European Journal of Medicinal Chemistry|January 27, 2020
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaignPasquale Linciano, Gregorio Cullia, Chiara Borsari, et al.
ACS Chemical Biology|November 27, 2014
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1João Neres, Ruben C Hartkoorn, Laurent R Chiarelli, et al.
European Journal of Medicinal Chemistry|September 23, 2019
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomicsChiara Borsari, María Dolores Jiménez-Antón, Julia Eick, et al.
Pediatrics|October 13, 2023
Early Postnatal Infection of Neonates Born to Mothers Infected by SARS-CoV-2 Omicron VariantCarlo Pietrasanta, Andrea Ronchi, Massimo Agosti, et al.
European Journal of Medicinal Chemistry|January 9, 2017
Methoxylated 2'-hydroxychalcones as antiparasitic hit compoundsChiara Borsari, Nuno Santarem, Juan Torrado, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2023
SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of NeonatologyLorenza Pugni, Beatrice Letizia Crippa, Francesco Raimondi, et al.
Journal of Medicinal Chemistry|July 15, 2016
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic DrugsChiara Borsari, Rosaria Luciani, Cecilia Pozzi, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery PlatformCarolina B Moraes, Gesa Witt, Maria Kuzikov, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
European Journal of Medicinal Chemistry|January 27, 2020
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaignPasquale Linciano, Gregorio Cullia, Chiara Borsari, et al.
ACS Chemical Biology|November 27, 2014
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1João Neres, Ruben C Hartkoorn, Laurent R Chiarelli, et al.
European Journal of Medicinal Chemistry|September 23, 2019
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomicsChiara Borsari, María Dolores Jiménez-Antón, Julia Eick, et al.
Pediatrics|October 13, 2023
Early Postnatal Infection of Neonates Born to Mothers Infected by SARS-CoV-2 Omicron VariantCarlo Pietrasanta, Andrea Ronchi, Massimo Agosti, et al.
European Journal of Medicinal Chemistry|January 9, 2017
Methoxylated 2'-hydroxychalcones as antiparasitic hit compoundsChiara Borsari, Nuno Santarem, Juan Torrado, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2023
SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of NeonatologyLorenza Pugni, Beatrice Letizia Crippa, Francesco Raimondi, et al.
Journal of Medicinal Chemistry|July 15, 2016
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic DrugsChiara Borsari, Rosaria Luciani, Cecilia Pozzi, et al.
ACS Omega|October 7, 2017
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug DiscoveryPasquale Linciano, Alice Dawson, Ina Pöhner, et al.
Elife|December 7, 2022
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growthLuca Costantino, Stefania Ferrari, Matteo Santucci, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 21, 2019
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery PlatformCarolina B Moraes, Gesa Witt, Maria Kuzikov, et al.
Pageof 13